Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective

High‐dose BEAM chemotherapy (BCNU, etoposide, Ara‐C, and melphalan) followed by autologous hematopoietic stem cell transplantation is frequently used as consolidative therapy for patients with recurrent or refractory Hodgkin or non‐Hodgkin lymphoma. The BEAM regimen has traditionally been administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, Robin M., Baran, Andrea, Friedberg, Jonathan W., Phillips, Gordon L., Liesveld, Jane L., Becker, Michael W., Wedow, Lucy, Barr, Paul M., Milner, Laurie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119960/
https://www.ncbi.nlm.nih.gov/pubmed/27699999
http://dx.doi.org/10.1002/cam4.879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119960/
https://www.ncbi.nlm.nih.gov/pubmed/27699999
http://dx.doi.org/10.1002/cam4.879

Ejemplares similares